| Firm | Analyst |
| Maxim Group | Yale Jen, PhD |
| Ladenburg Thalmann | Matt Kaplan |
| Zacks Investment Research | Jason Napodano |
Nile Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Nile Therapeutics' performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Nile Therapeutics or its management. Nile Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. |
